There are approximately 15% of people who, after a SARS-CoV-2 infection, maintain a set of symptoms for several months regardless of their acute COVID. This symptomatology is also referred to as "prolonged COVID", "chronic COVID syndrome", "long COVID" or "post-acute COVID syndrome".
According to the survey conducted by the Spanish Society of General and Family Physicians (SEMG) and the LONG COVID ACTS affected collectives, persistent COVID is more frequent in women (79%), in middle age, although it can present at any age and with persistent symptoms for more than 6 months.
Independently of the routine tests that are performed in all patients with varied and persistent symptomatology, we specifically perform a LONG COVID cytokine panel, consisting of the quantification of IL-2, IL-4, IL-6, IL-8, IL-10, IL-13, CD-40 ligand, CCL3, CCL4, CCL5 (RANTES), TNF-alpha, IFN gamma and VEGF (vascular endothelial growth factor).
Depending on the results, we will know the patient's situation and will be able to establish the most appropriate treatment.
Depending on the analytical results, we prescribe a master formulation that reduces inflammatory cytokines, increases anti-inflammatory ones and regulates the affected growth factors. In addition, we always protocolize a personalized treatment based on Biological Medicine and the latest medical advances on the subject, so that the patient improves progressively and that, finally, his immune system is effective and able to perform its defensive work.
Si los síntomas son muy molestos y el paciente tiene una muy mala calidad de vida, con frecuencia es muy eficaz para una reducción casi instantánea de los mismos, mientras el resto del tratamiento va haciendo efecto, realizarle al paciente un ciclo de INUSpheresis® en el que vamos a filtrar la sangre del paciente, eliminando de golpe las citoquinas inflamatorias en exceso e incluso la proteina spike, que son las causantes de la sintomatología. Además, con la INUSpheresis® eliminamos la toxicidad por metales pesados, productos químicos y micotoxinas, que en realidad son los que están manteniendo la deficiencia inmunitaria y la sintomatología del paciente.